Skip to main content
. 2019 Nov 14;9:16862. doi: 10.1038/s41598-019-53239-6

Figure 3.

Figure 3

Total extracts of A549 cells untreated (control) or treated with pinometostat 1 μM (EPZ) during the indicated times were used for (A) Western blot against the specified proteins, (B) immunofluorescence analysis against H3K79me2 and (C) colorimetric detection of H3K79me2. (D) Viability of A549 cells treated with 1 μM DOT1L inhibitor was determined by MTT assay to measure cell metabolic activity.